Oxytocin-Related Trial on Digital Prenatal Education Registered

On 2026-08-04, a new clinical trial titled "Digital Prenatal Education to Reduce Fear of Childbirth in Term Pregnancy" was registered on ClinicalTrials.gov under identifier NCT07743502. The trial's status is listed as not yet recruiting. Its phase is listed as NA, indicating it is not a traditional drug-phase clinical trial. Oxytocin, an approved compound, is associated with this trial record. No results have been posted for this study at this time. The registration reflects only the trial's setup and planned scope as described in the listing. No outcomes, efficacy data, or safety findings are available yet, since the study has not begun recruiting participants. Further updates would be expected as the trial progresses through recruitment and subsequent phases. Readers interested in the broader context of oxytocin, including its approved uses and regulatory status, can consult the compound overview for additional background.